Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
NCT00716157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2014-12-05
Summary
Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.
Conditions
- Cancer of the Head and Neck
- Cancer of the Lung
- Cancer of the Esophagus
- Gastro-esophageal Junction Cancer
Sponsors & Collaborators
- collaborator INDUSTRY
-
Thomas Jefferson University
lead OTHER
Principal Investigators
-
Rita Axelrod, MD · Thomas Jefferson University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
- Primary Completion
- 2008-08-31
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients
NCT02403037 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting
NCT01993381 ·Status: UNKNOWN
-
Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting
NCT01581918 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevalence of Delayed Chemotherapy Associated Nausea
NCT04342780 ·Status: COMPLETED
-
Relief Band as an Adjunct to Antiemetic Therapy in Patients Who Receive Mod to Highly Emetogenic Chemotherapy
NCT01980160 ·Status: WITHDRAWN ·Phase: NA
-
Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting
NCT01432015 ·Status: COMPLETED ·Phase: PHASE4
-
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
NCT00880191 ·Status: COMPLETED ·Phase: PHASE3
-
Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy
NCT01661413 ·Status: COMPLETED
-
Predict CHimio-or Radiation-induced NAusea and Vomiting in Children/adolescents Treated for Cancer
NCT06869005 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer
NCT05841849 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
NCT06120764 ·Status: RECRUITING ·Phase: NA
-
Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)
NCT00092196 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy
NCT01402024 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
NCT07169851 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Short-term Therapeutic Fasting on Nausea and Vomiting Due to Chemotherapy
NCT04141514 ·Status: RECRUITING ·Phase: NA
-
An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)
NCT00092183 ·Status: COMPLETED ·Phase: PHASE4
-
Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)
NCT00952341 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting
NCT00250744 ·Status: COMPLETED ·Phase: PHASE2
-
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
NCT03040726 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
NCT00903396 ·Status: TERMINATED ·Phase: PHASE2
-
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
NCT01492569 ·Status: WITHDRAWN ·Phase: NA
-
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting
NCT05143554 ·Status: TERMINATED ·Phase: NA
-
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
NCT06200168 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
NCT07130617 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
NCT06314906 ·Status: RECRUITING ·Phase: PHASE3